| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
195,811,000 |
| Market
Cap: |
1.23(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$3.08 - $6.74 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile ADMA Biologics is an end-to-end commercial biopharmaceutical company focused on manufacturing, marketing and developing plasma-derived biologics for the treatment of immunodeficient patients at risk for infectious diseases. Co.'s products include: BIVIGAM (Immune Globulin Intravenous, Human), an Intravenous Immune Globulin (IVIG) product indicated for the treatment of Primary Humoral Immunodeficiency (PI); ASCENIV (Immune Globulin Intravenous, Human – slra 10% Liquid), an IVIG product indicated for the treatment of PI; and Nabi-HB (Hepatitis B Immune Globulin, Human), which is indicated for the treatment of acute exposure to blood containing HBsAg and other listed exposures to Hepatitis B.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
155,000 |
191,958 |
| Total Buy Value |
$0 |
$0 |
$579,644 |
$685,344 |
| Total People Bought |
0 |
0 |
2 |
4 |
| Total Buy Transactions |
0 |
0 |
2 |
5 |
| Total Shares Sold |
1,500,000 |
1,500,000 |
4,083,538 |
4,083,538 |
| Total Sell Value |
$9,143,159 |
$9,143,159 |
$19,811,348 |
$19,811,348 |
| Total People Sold |
1 |
1 |
4 |
4 |
| Total Sell Transactions |
5 |
5 |
11 |
11 |
| End Date |
2024-01-21 |
2023-10-20 |
2023-04-21 |
2022-04-21 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kestenberg-Messina Kaitlin M. |
COO and SVP, Compliance |
• – – |
2024-04-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
114,275 |
|
-5% |
|
| Kestenberg-Messina Kaitlin M. |
COO and SVP, Compliance |
• • – |
2024-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
192,320 |
304,510 |
|
- |
|
| Grossman Adam S |
President,CEO, and Interim CFO |
• • – |
2024-03-31 |
4 |
D |
$6.60 |
$143,563 |
D/D |
(21,752) |
2,651,475 |
|
- |
|
| Kestenberg-Messina Kaitlin M. |
COO and SVP, Compliance |
• • – |
2024-03-31 |
4 |
D |
$6.60 |
$13,761 |
D/D |
(2,085) |
112,190 |
|
- |
|
| Elms Steve |
|
• • – |
2024-03-19 |
4 |
S |
$6.08 |
$2,503,920 |
I/I |
(411,829) |
2,115,671 |
|
-0% |
|
| Elms Steve |
|
• • – |
2024-03-18 |
4 |
S |
$6.01 |
$299,821 |
I/I |
(49,887) |
2,527,500 |
|
-4% |
|
| Elms Steve |
|
• • – |
2024-03-15 |
4 |
S |
$6.01 |
$1,099,878 |
I/I |
(183,008) |
2,577,387 |
|
-4% |
|
| Elms Steve |
|
• • – |
2024-03-14 |
4 |
S |
$6.05 |
$2,712,070 |
I/I |
(448,276) |
2,760,395 |
|
-3% |
|
| Elms Steve |
|
• • – |
2024-03-13 |
4 |
S |
$6.21 |
$2,527,470 |
I/I |
(407,000) |
3,208,671 |
|
1% |
|
| Lenz Brian |
EVP, CFO |
• • – |
2024-03-07 |
4 |
D |
$6.16 |
$104,504 |
D/D |
(16,965) |
703,002 |
|
- |
|
| Grossman Adam S |
President and CEO |
• • – |
2024-03-07 |
4 |
D |
$6.16 |
$177,180 |
D/D |
(28,763) |
2,673,227 |
|
- |
|
| Lenz Brian |
EVP, CFO |
• • – |
2024-03-06 |
4 |
D |
$6.12 |
$102,063 |
D/D |
(16,677) |
719,967 |
|
- |
|
| Grossman Adam S |
President and CEO |
• • – |
2024-03-06 |
4 |
D |
$6.12 |
$336,618 |
D/D |
(55,003) |
2,701,990 |
|
- |
|
| Grossman Adam S |
President and CEO |
• • – |
2024-02-29 |
4 |
D |
$5.36 |
$51,392 |
D/D |
(9,588) |
2,756,993 |
|
- |
|
| Lenz Brian |
EVP, CFO |
• • – |
2024-02-29 |
4 |
D |
$5.36 |
$26,452 |
D/D |
(4,935) |
736,644 |
|
- |
|
| Finger Alison Cecily |
|
• • – |
2024-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
24,040 |
24,040 |
|
- |
|
| Grossman Jerrold B |
|
• • – |
2024-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
24,040 |
467,305 |
|
- |
|
| Kwon Young |
|
• • – |
2024-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
24,040 |
301,441 |
|
- |
|
| Guiheen Lawrence P. |
|
• • – |
2024-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
24,040 |
153,941 |
|
- |
|
| Elms Steve |
|
• • – |
2024-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
24,040 |
76,441 |
|
- |
|
| Grossman Adam S |
President and CEO |
• • – |
2024-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
557,728 |
2,766,581 |
|
- |
|
| Fong Bryant |
|
• • – |
2024-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
24,040 |
83,941 |
|
- |
|
| Grossman Adam S |
President and CEO |
• • – |
2024-02-25 |
4 |
D |
$5.26 |
$118,124 |
D/D |
(22,457) |
2,208,853 |
|
- |
|
| Lenz Brian |
EVP, CFO |
• • – |
2024-02-25 |
4 |
D |
$5.26 |
$43,432 |
D/D |
(8,257) |
741,579 |
|
- |
|
| Lenz Brian |
EVP, CFO |
• • – |
2023-12-31 |
4 |
D |
$4.52 |
$76,424 |
D/D |
(16,908) |
749,836 |
|
- |
|
222 Records found
|
|
Page 1 of 9 |
|
|
0.07 (1.13%) 
